Mechanisms underlying gait disturbance in Parkinson's disease. A single photon emission computed tomography study

Brain

Volumn 122, Issue 7, 1999, Pages 1271-1282

  Hanakawa, Takashi ^a   Katsumi, Yukinori ^a   Fukuyama, Hidenao ^a   Honda, Manabu ^a   Hayashi, Takuya ^a   Kimura, Jun ^a   Shibasaki, Hiroshi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Activation study; Gait disturbance; Locomotor centre; Parkinson's disease; Single photon emission computed tomography (SPECT)

Indexed keywords

CONTRAST MEDIUM; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BASAL GANGLION; BRAIN BLOOD FLOW; BRAIN STEM; CEREBELLUM; CEREBELLUM VERMIS; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; FEMALE; FRONTAL LOBE; GAIT DISORDER; HUMAN; INSULA; MALE; PARIETAL LOBE; PARKINSON DISEASE; PREMOTOR CORTEX; PRIORITY JOURNAL; SENSORIMOTOR CORTEX; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL CORTEX; TREADMILL; VISUAL CORTEX;

AGED; BRAIN; CEREBROVASCULAR CIRCULATION; FEMALE; GAIT; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; PARKINSON DISEASE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032767876     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/122.7.1271     Document Type: Article

References (48)

1. Albin RL, Minoshima S, D'Amato CJ, Frey KA, Kuhl DA, Sima AA. Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology 1996; 47: 462-6.
2. Alexander GE, Crutcher MD. Functional architecture of basal ganglia circuits: neural substrates of parallel processing [see comments]. [Review]. Trends Neurosci 1990; 13: 266-71. Comment in: Trends Neurosci 1991; 14: 35-9.
3. Alexander GE, Crutcher MD. Functional architecture of basal ganglia circuits: neural substrates of parallel processing [see comments]. [Review]. Trends Neurosci 1990; 13: 266-71. Comment in: Trends Neurosci 1991; 14: 35-9.
4. Andersen AR, Friberg HH, Schmidt JF, Hasselbalch SG. Quantitative measurements of cerebral blood flow using SPECT and [99mTc]-d, 1-HM-PAO compared to xenon-133. J Cereb Blood Flow Metab 1988; 8: S69-81.
5. Asanome M, Matsuyama K, Mori S. Augmentation of postural muscle tone induced by the stimulation of the descending fibers in the midline area of the cerebellar white matter in the acute decerebrate cat. Neurosci Res 1998; 30: 257-69.
6. Augustine JR. Circuitry and functional aspects of the insular lobe in primates including humans. [Review]. Brain Res Brain Res Rev 1996; 22: 229-44.
7. Bailey DL, Jones T, Friston KJ, Colebatch JG, Frackowiak RSJ. Physical validation of statistical parametric mapping [abstract]. J Cereb Blood Flow Metab 1991; 11 Suppl 2: S150.
8. Bodis-Wollner I. Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients. [Review]. Trends Neurosci 1990; 13: 296-302.
9. Caplan LR, Goodwin JA. Lateral tegmental brainstem hemorrhages. Neurology 1982; 32: 252-60.
10. Ceballos-Baumann AO, Passingham RE, Warner T, Playford ED, Marsden CD, Brooks DJ. Overactive prefrontal and underactive motor cortical areas in idiopathic dystonia. Ann Neurol 1995; 37: 373-2.
11. Decety J, Perani D, Jeannerod M, Bettinardi V, Tadary B, Woods R, et al. Mapping motor representations with positron emission tomography. Nature 1994; 371: 600-2.
12. DeLong MR. Primate models of movement disorders of basal ganglia origin. [Review]. Trends Neurosci 1990; 13: 281-5.
13. Eidelberg E, Walden JG, Nguyen LH. Locomotor control in macaque monkeys. Brain 1981; 104: 647-63.
14. Evans AC, Kamber M, Collins DL, Macdonald D. An MRI-based probabilistic atlas of neuroanatomy. In: Shorvon S, Fish D, Andermann F, Bydder GM, Stefan H, editors. Magnetic resonance scanning and epilepsy, NATO ASI Series A, Life Sciences, Vol. 264, New York: Plenum; 1994. p. 263-74.
15. Fahn S, Elton R, Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Calne DB, Goldstein M, editors. Recent developments in Parkinson's disease, Vol. 2. Florham Park (NJ): Macmillan Health Care Information, 1987: 153-63, 293-304.
16. Friston KJ, Ashburner J, Frith CD, Poline JB, Heather JD, Frackowiak RSJ. Spatial registration and normalization of images. Hum Brain Mapp 1995a; 3: 165-89.
17. Friston KJ, Holmes AP, Worsley KJ, Poline JB, Frith CD, Frackowiak RSJ. Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 1995b; 2: 189-210.
18. 99mTc]HMPAO. Neuroreport 1996; 7: 3009-12.
19. Fukuyama H, Ouchi Y, Matsuzaki S, Nagahama Y, Yamauchi H, Ogawa M, et al. Brain functional activity during gait in normal subjects: a SPECT study. Neurosci Lett 1997a; 228: 183-6.
20. Fukuyama H, Ouchi Y, Matsuzaki S, Hanakawa T, Nagahama Y, Shibasaki H. Brain functional activity during gait in Parkinson's disease [abstract]. Mov Disord 1997b; 12 Suppl 1: 12.
21. Garcia-Rill E. The basal ganglia and the locomotor regions. [Review]. Brain Res 1986; 396: 47-63.
22. Grafton ST, Waters C, Sutton J, Lew MF, Couldwell W. Pallidotomy increases activity of motor association cortex in Parkinson's disease: a positron emission tomographic study. Ann Neurol 1995; 37: 776-83.
23. Hanakawa T, Fukuyama H, Katsumi Y, Hayashi T, Kimura J, Shibasaki H. Cerebral blood flow activation study of gait disturbance in Parkinson's disease [abstract]. Neurology 1998; 50 Suppl 4: A391.
24. Hanakawa T, Fukuyama H, Katsumi Y, Honda M, Shibasaki H. Enhanced lateral premotor activity during paradoxical gait in Parkinson disease. Ann Neurol 1999; 45: 329-36.
25. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases [see comments]. J Neurol Neurosurg Psychiatry 1992; 55: 181-4. Comment in: J Neurol Neruosurg Psychiatry 1993; 56: 938-9.
26. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases [see comments]. J Neurol Neurosurg Psychiatry 1992; 55: 181-4. Comment in: J Neurol Neruosurg Psychiatry 1993; 56: 938-9.
27. Kuypers HG, Lawrence DG. Cortical projections to the red nucleus and the brain stem in the Rhesus monkey. Brain Res 1967; 4: 151-88.
28. Markus HS, Costa DC, Lees AJ. HMPAO SPECT in Parkinson's disease before and after levodopa: correlation with dopaminergic responsiveness. J Neurol Neurosurg Psychiatry 1994; 57: 180-5.
29. Marshall RS, Lazar RM, Van Heertum RL, Esser PD, Perera GM, Mohr JP. Changes in regional cerebral blood flow related to line bisection discrimination and visual attention using HMPAO-SPECT. Neuroimage 1997; 6: 139-44.
30. Martin JP. Locomotion and the basal ganglia. In: Martin JP. The basal ganglia and posture. London: Pitman Medical; 1967. p. 20-35.
31. Masdeu JC, Alampur U, Cavaliere R, Tavoulareas G. Astasia and gait failure with damage of the pontomesencephalic locomotor region. Ann Neurol 1994; 35: 619-21.
32. Mori S, Sakamoto T, Ohta Y, Takakusaki K, Matsuyama K. Site-specific postural and locomotor changes evoked in awake, freely moving intact cats by stimulating the brainstem. Brain Res 1989; 505: 66-74.
33. Morris ME, Iansek R, Matyas TA, Summers JJ. The pathogenesis of gait hypokinesia in Parkinson's disease. Brain 1994; 117:1169-81.
34. Nutt JG, Marsden CD, Thompson PD. Human walking and higher-level gait disorders, particularly in the elderly [see comments]. [Review]. Neurology 1993; 43: 268-79. Comment in: Neurology 1994; 44: 779-80.
35. Nutt JG, Marsden CD, Thompson PD. Human walking and higher- level gait disorders, particularly in the elderly [see comments]. [Review]. Neurology 1993; 43: 268-79. Comment in: Neurology 1994; 44: 779-80.
36. Oku N, Matsumoto M, Hashikawa K, Moriwaki H, Okazaki Y, Seike Y, et al. Carbon dioxide reactivity by consecutive technetium-99m-HMPAO SPECT in patients with a chronically obstructed major cerebral artery [see comments]. J Nucl Med 1994; 35: 32-40. Comment in: J Nucl Med 1994; 35: 41-3 .
37. Oku N, Matsumoto M, Hashikawa K, Moriwaki H, Okazaki Y, Seike Y, et al. Carbon dioxide reactivity by consecutive technetium- 99m-HMPAO SPECT in patients with a chronically obstructed major cerebral artery [see comments]. J Nucl Med 1994; 35: 32- 40. Comment in: J Nucl Med 1994; 35: 41-3 .
38. Pantano P, Di Piero V, Ricci M, Fieschi C, Bozzao L, Lenzi GL. Motor stimulation response by technetium-99m-hexamethylpropylene amine oxime split-dose method and single photon emission tomography. Eur J Nucl Med 1992; 19: 939-45.
39. Picard N, Strick PL. Motor areas of the medial wall: a review of their location and functional activation. [Review]. Cereb Cortex 1996; 6: 342-53.
40. Playford ED, Jenkins IH, Passingham RE, Nutt J, Frackowiak RS, Brooks DJ. Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study. Ann Neurol 1992; 32: 151-61.
41. Rascol O, Sabatini U, Chollet F, Celsis P, Montastruc JL, Marc-Vergnes JP, et al. Supplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine. Arch Neurol 1992; 49: 144-8.
42. Rascol O, Sabatini U, Fabre N, Brefel C, Loubinoux I, Celsis P, et al. The ipsilateral cerebellar hemisphere is overactive during hand movements in akinetic parkinsonian patients. Brain 1997; 120: 103-10.
43. Samuel M, Ceballos-Baumann AO, Blin J, Uema T, Boecker H, Passingham RE, et al. Evidence for lateral premotor and parietal overactivity in Parkinson's disease during sequential and bimanual movements: a PET study [see comments]. Brain 1997a; 120: 963-76. Comment in: Brain 1998; 121: 769-72 .
44. Samuel M, Ceballos-Baumann AO, Blin J, Uema T, Boecker H, Passingham RE, et al. Evidence for lateral premotor and parietal overactivity in Parkinson's disease during sequential and bimanual movements: a PET study [see comments]. Brain 1997a; 120: 963- 76. Comment in: Brain 1998; 121: 769-72 .
45. 15O PET study. Brain 1997b; 120: 1301-13.
46. Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. Stuttgart: Thieme; 1988.
47. Wall JC, Turnbull GI. The kinematics of gait. In: Turnbull GI editor. Physical therapy management of Parkinson's disease. New York: Churchill Livingstone; 1992. p. 49-67.
48. Webster D. Clinical analysis of the disability in Parkinson's disease. Mod Treat 1968; 5: 257-82.